Publications

• Schettler V, Jaeger B, Klingel R.

  The German Lipid Apheresis Registry – remaining to be established.

  
  Atherosclerosis. Supplements

  10 (5) , 59-61
  (2009)

  PubMed ID:(20129377)

• Schettler V, Wieland E.

  A case report of darbepoetin treatment in a patient with sickle cell disease and chronic renal failure undergoing regular hemodialysis procedures that induce a dose-dependent extension of blood transfusion intervals.

  
  Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy

  13 (1) , 80-2
  (2009)

  PubMed ID:(19379175)

• Schulz E, Bahri S, Schettler V, Popov A, Hermann M.

  Pharmacokinetics and antihypertensive effects of candesartan cilexetil in patients undergoing haemodialysis: an open-label, single-centre study.

  
  Clinical drug investigation

  29 (11) , 713-9
  (2009)

  PubMed ID:(19813774)

• Schettler V, Wieland E.

  [Effects of LDL-apheresis–more than reduction of cholesterol?]

  
  Deutsche medizinische Wochenschrift (1946)

  132 (11) , 575-8
  (2007)

  PubMed ID:(17342636)

• Scheel A, Schettler V, Koziolek M, Koelling S, Werner C, M?ller G, Strutz F.

  Impact of chronic LDL-apheresis treatment on Achilles tendon affection in patients with severe familial hypercholesterolemia: a clinical and ultrasonographic 3-year follow-up study.

  
  Atherosclerosis

  174 (1) , 133-9
  (2004)

  PubMed ID:(15135262)

• Tings T, Schettler V, Canelo M, Paulus W, Trenkwalder C.

  Impact of regular LDL apheresis on the development of restless legs syndrome.

  
  Movement disorders : official journal of the Movement Disorder Society

  19 (9) , 1072-5
  (2004)

  PubMed ID:(15372599)

• Schettler V, Krontal J, Scheel A, Wieland E.

  No acute impact of lipid apheresis treatment on free radical scavenging enzyme gene expression in white blood cells.

  
  European journal of clinical investigation

  33 (2) , 134-40
  (2003)

  PubMed ID:(12588287)

• Schettler V, K?hn W, Kleinoeder T, Armstrong V, Oellerich M, M?ller G, Wieland E.

  No acute impact of haemodialysis treatment on free radical scavenging enzyme gene expression in white blood cells.

  
  Journal of internal medicine

  253 (2) , 201-7
  (2003)

  PubMed ID:(12542561)

• Schettler V, Wieland E, Armstrong V, Kleinoeder T, Grunewald R, M?ller G.

  First steps toward the establishment of a German low-density lipoprotein-apheresis registry: recommendations for the indication and for quality management.

  
  Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis

  6 (5) , 381-3
  (2002)

  PubMed ID:(12423533)

• Wieland E, Schettler V, Armstrong V.

  Highly effective reduction of C-reactive protein in patients with coronary heart disease by extracorporeal low density lipoprotein apheresis.

  
  Atherosclerosis

  162 (1) , 187-91
  (2002)

  PubMed ID:(11947913)

• Berner B, Scheel A, Schettler V, Hummel K, Reuss-Borst M, M?ller G, Oestmann E, Leinenbach H, Hepper M.

  Rapid improvement of SLE-specific cutaneous lesions by C1q immunoadsorption.

  
  Annals of the rheumatic diseases

  60 (9) , 898-9
  (2001)

  PubMed ID:(11534506)

• Grunewald R, Oppermann M, Schettler V, Fiedler G, Jehle P, Schuettert J.

  Polarized function of thick ascending limbs of Henle cells in osmoregulation.

  
  Kidney international

  60 (6) , 2290-8
  (2001)

  PubMed ID:(11737602)

• Schettler V, Monazahian M, Wieland E, Ramadori G, Grunewald R, Thomssen R, M?ller G.

  Reduction of hepatitis C virus load by H.E.L.P.-LDL apheresis.

  
  European journal of clinical investigation

  31 (2) , 154-5
  (2001)

  PubMed ID:(11168454)

• Schettler V, Monazahian M, Wieland E, Thomssen R, M?ller G.

  Effect of heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) apheresis on hepatitis C plasma virus load.

  
  Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis

  5 (5) , 384-6
  (2001)

  PubMed ID:(11778924)

• Schettler V, Methe H, Schuff-Werner P, M?ller G, Wieland E.

  Acute effect of H.E.L.P. treatment on radical scavenging enzyme activities, total glutathione concentrations in granulocytes, and selenium in plasma.

  
  European journal of clinical investigation

  30 (1) , 26-32
  (2000)

  PubMed ID:(10619998)

• Schettler V, Methe H, Staschinsky D, Schuff-Werner P, M?ller G, Wieland E.

  Review: the oxidant/antioxidant balance during regular low density lipoprotein apheresis.

  
  Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis

  3 (3) , 219-26
  (1999)

  PubMed ID:(10427619)

• Schuff-Werner P, Schettler V.

  [Plaque stabilization by LDL apheresis?]

  
  Herz

  24 (1) , 57-61
  (1999)

  PubMed ID:(10093014)

• Schettler V, Wieland E, Methe H, Schuff-Werner P, M?ller G.

  Oxidative stress during dialysis: effect on free radical scavenging enzyme (FRSE) activities and glutathione (GSH) concentration in granulocytes.

  
  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association – European Renal Association

  13 (10) , 2588-93
  (1998)

  PubMed ID:(9794565)

• Schettler V, Wieland E, Methe H, Schuff-Werner P, Oellerich M, M?ller G.

  Activity of free radical scavenging enzymes in red cells and plasma of patients undergoing extracorporeal low-density lipoprotein apheresis.

  
  Artificial organs

  22 (2) , 123-8
  (1998)

  PubMed ID:(9491901)

• Schuff-Werner P, Schettler V, Schulz E.

  Cholesterol-lowering therapy.

  
  Circulation

  96 (10) , 3801-2
  (1997)

  PubMed ID:(9396506 )

• M?ller G, Schettler V, M?ller C, Strutz F.

  Prevention of progression of renal fibrosis: how far are we?

  
  Kidney international. Supplement

  54 , S75-82
  (1996)

  PubMed ID:(8731200)

• Wieland E, Schettler V, Creutzfeldt C, Kickbusch H, Schuff-Werner P.

  Lack of plasma lipid peroxidation during LDL-apheresis by heparin-induced extracorporeal LDL-precipitation.

  
  European journal of clinical investigation

  25 (11) , 838-42
  (1995)

  PubMed ID:(8582449)

• Schettler V, Wieland E, Verwiebe R, Schuff-Werner P, Scheler F, Oellerich M.

  Plasma lipids are not oxidized during hemodialysis.

  
  Nephron

  67 (1) , 42-7
  (1994)

  PubMed ID:(8052366)

• Wieland E, Schettler V, Diedrich F, Schuff-Werner P, Oellerich M.

  Determination of lipid hydroperoxides in serum iodometry and high performance liquid chromatography compared.

  
  European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies

  30 (6) , 363-9
  (1992)

  PubMed ID:(1511071)

• Scheel A, Blaschke S, Schettler V, Mayer C, M?ller G, Bittermann H, Grunewald R.

  Severe neurotoxicity of tacrolimus (FK506) after renal transplantation: two case reports.

  
  Transplantation proceedings

  33 (7-8) , 3693-4

  PubMed ID:(11750573)